AAAAAA
Results:
1-7
|
Results: 7
Authors:
RUTTENVANMOLKEN MPMH
VANDOORSLAER EKA
TILL MD
Citation: Mpmh. Ruttenvanmolken et al., INTERNATIONAL COST-EFFECTIVENESS STUDY COMPARING FORMOTEROL (FORADIL(TM)) AND SALMETEROL (SEREVENT(R)), Journal of allergy and clinical immunology, 101(1), 1998, pp. 294-294
Authors:
VANDOORSLAER EKA
TORMANS G
GUPTA AK
VANROSSEM K
EGGLESTON A
DUBOIS DJ
DEDONCKER P
HANEKE E
Citation: Eka. Vandoorslaer et al., ECONOMIC-EVALUATION OF ANTIFUNGAL AGENTS IN THE TREATMENT OF TOENAIL ONYCHOMYCOSIS IN GERMANY, Dermatology, 193(3), 1996, pp. 239-244
Authors:
RUTTENVANMOLKEN MPMH
VANDOORSLAER EKA
JANSEN MCC
KERSTJENS HAM
RUTTEN FFH
Citation: Mpmh. Ruttenvanmolken et al., COSTS AND EFFECTS OF INHALED CORTICOSTEROIDS AND BRONCHODILATORS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, American journal of respiratory and critical care medicine, 151(4), 1995, pp. 975-982
Authors:
RUTTENVANMOLKEN MPMH
CUSTERS F
VANDOORSLAER EKA
JANSEN CCM
HEURMAN L
MAESEN FPV
SMEETS JJ
BOMMER AM
RAAIJMAKERS JAM
Citation: Mpmh. Ruttenvanmolken et al., COMPARISON OF PERFORMANCE OF 4 INSTRUMENTS IN EVALUATING THE EFFECTS OF SALMETEROL ON ASTHMA QUALITY-OF-LIFE, The European respiratory journal, 8(6), 1995, pp. 888-898
Authors:
RUTTENVANMOLKEN MPMH
BAKKER CH
VANDOORSLAER EKA
VANDERLINDEN S
Citation: Mpmh. Ruttenvanmolken et al., METHODOLOGICAL ISSUES OF PATIENT UTILITY MEASUREMENT - EXPERIENCE FROM 2 CLINICAL-TRIALS, Medical care, 33(9), 1995, pp. 922-937
Authors:
RUTTENVANMOLKEN MPMH
VANDOORSLAER EKA
VANVLIET RCJA
Citation: Mpmh. Ruttenvanmolken et al., STATISTICAL-ANALYSIS OF COST OUTCOMES IN A RANDOMIZED CONTROLLED CLINICAL-TRIAL, Health economics, 3(5), 1994, pp. 333-345
Authors:
RUTTENVANMOLKEN MPMH
VANDOORSLAER EKA
JANSEN MCC
VANESSENZANDVLIET EE
RUTTEN FFH
Citation: Mpmh. Ruttenvanmolken et al., COST-EFFECTIVENESS OF INHALED CORTICOSTEROID PLUS BRONCHODILATOR THERAPY VERSUS BRONCHODILATOR MONOTHERAPY IN CHILDREN WITH ASTHMA, PharmacoEconomics, 4(4), 1993, pp. 257-270
Risultati:
1-7
|